Frontiers in Oncology (Aug 2022)

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

  • Yin Yang,
  • Jianyang Wang,
  • Wenqing Wang,
  • Tao Zhang,
  • Jingjing Zhao,
  • Yu Wang,
  • Yexiong Li,
  • Luhua Wang,
  • Nan Bi

DOI
https://doi.org/10.3389/fonc.2022.1007862
Journal volume & issue
Vol. 12

Abstract

Read online

No abstracts available.

Keywords